EOM Pharmaceuticals Holdings, Inc.
OTC: IMUC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Irach Taraporewala
- Employees
- 3
- Headquarters
- Montvale, United States
- IPO year
- 2021
- Market cap
- $21.6M
- Website
- https://www.eompharma.com
Loading IMUC…
Loading profile data…Frequently asked questions about IMUC
What does EOM Pharmaceuticals Holdings, Inc. (IMUC) do?
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medications. These treatments hold the potential to revolutionize existing therapeutic approaches. Among its key drug candidates currently undergoing development are EOM613 and EOM147. Established on March 20, 1987, the company mainta...
Where does IMUC trade?
EOM Pharmaceuticals Holdings, Inc. (IMUC) trades on the Other OTC.
What sector is IMUC in?
EOM Pharmaceuticals Holdings, Inc. (IMUC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of EOM Pharmaceuticals Holdings, Inc.?
Irach Taraporewala is the chief executive officer of EOM Pharmaceuticals Holdings, Inc. (IMUC).
Where is EOM Pharmaceuticals Holdings, Inc. headquartered?
EOM Pharmaceuticals Holdings, Inc. is headquartered in United States.
Does IMUC pay a dividend?
EOM Pharmaceuticals Holdings, Inc. (IMUC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IMUC go public?
EOM Pharmaceuticals Holdings, Inc. (IMUC) completed its initial public offering in 2021.